Other disorders of the musculoskeletal system and connective tissue

M13_MUSCULOSKELEOTH

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M95-M99 Cause of death: ICD-10 — M95-M99 2 out of 7 registries used, show all original rules.	4370
4. Check minimum number of events None	4370
5. Include endpoints M13_DEFORMACQ M13_POSTOPMUSCULOSKE M13_BIOMECHLESIO	5940
6. Filter based on genotype QC (FinnGen only)	5940

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	M13_MUSCULOSKELEOTH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_DEFORMACQ\|M13_POSTOPMUSCULOSKE\|M13_BIOMECHLESIO
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M9[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M9[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of the musculoskeletal system and connective tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42034	22263	19467
Only index persons	37295	20148	17147
Unadjusted period prevalence (%)
Whole population	0.59	0.64	0.54
Only index persons	0.70	0.74	0.65
Median age at first event (years)
Whole population	50.65	53.46	47.40
Only index persons	49.27	52.21	45.81

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5940	3365	2575
Unadjusted period prevalence (%)	1.14	1.15	1.14
Median age at first event (years)	51.76	50.66	53.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5248: Matched controls
52478

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.4

323.0

1465

4225

M95.0

ICD-10 Finland

Acquired deformity of nose

4111.0

323.0

734

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

+∞

323.0

535

73808

ICD-8 Finland

Other deformities, Aliae definitae

+∞

323.0

325

N03AX16

ATC

pregabalin; oral

3.5

323.0

2028

7926

M48.0

ICD-10 Finland

Spinal stenosis

5.5

323.0

1497

3522

N02AX02

ATC

tramadol; systemic, rectal

3.3

323.0

3096

15968

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

5707.4

323.0

526

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

323.0

379

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

2400.9

323.0

767

N03AX12

ATC

gabapentin; oral

4.3

323.0

1568

4748

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

7.0

278.9

747

1218

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

275.7

1236

3617

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

207.9

267.5

276

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

196.1

251.9

261

DLD20

NOMESCO Finland

Rhinoplasty

349.6

235.2

236

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

12.1

234.8

446

400

7396A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Lower extremities

+∞

234.1

223

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

232.9

986

2691

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.0

206.3

932

2675

M43.1

ICD-10 Finland

Spondylolisthesis

6.9

205.1

548

874

M54.4

ICD-10 Finland

Lumbago with sciatica

3.2

201.3

1307

4994

DLD10

NOMESCO Finland

Reconstruction of cartilage and bone of nose

292.1

193.4

196

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.4

188.2

2876

17833

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

7.2

182.5

469

704

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.1

180.8

781

2132

7384A

ICD-9 Finland

Other acquired deformity, Acquired spondylolisthesis

+∞

171.8

164

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.6

168.1

641

1545

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

8.2

164.1

385

501

9211

FHL

Exploration or removal of diskusprolapse

8.6

159.4

364

453

M54.5

ICD-10 Finland

Low back pain

2.3

157.7

2042

11341

M99.8

ICD-10 Finland

Other biomechanical lesions

786.2

156.2

153

N06AA09

ATC

amitriptyline; systemic

3.4

152.2

856

2882

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

11.1

150.7

296

280

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

6.3

149.2

423

722

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

144.9

2263

13557

73809

ICD-8 Finland

Other deformities, Unspecified

+∞

143.4

137

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

8.1

139.4

328

427

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

5.9

139.3

415

753

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

12.5

138.3

256

214

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

137.6

1156

5042

M79.6

ICD-10 Finland

Pain in limb

2.1

132.8

2138

12829

N06AX21

ATC

duloxetine; oral

3.1

128.8

822

3002

N02AA05

ATC

oxycodone; systemic

2.7

127.8

1039

4422

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

22.2

126.4

187

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

126.2

1700

9374

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

150.4

124.8

132

J34.2

ICD-10 Finland

Deviated nasal septum

4.3

122.8

489

1215

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

39.2

122.4

156

M99.9

ICD-10 Finland

Biomechanical lesion, unspecified

253.9

121.5

124

M99.0

ICD-10 Finland

Segmental and somatic dysfunction

162.6

120.8

127

M96.8

ICD-10 Finland

Other postprocedural musculoskeletal disorders

403.1

119.1

119

B01AB05

ATC

enoxaparin; parenteral

2.1

115.8

1853

10916

N02BE01

ATC

paracetamol; systemic, rectal

2.5

115.6

4628

39338

L03

ICPC

Low back symptom/complaint

2.2

114.3

1469

7857

M01AH05

ATC

etoricoxib; oral

1.9

113.5

3236

23746

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.0

111.4

325

571

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.7

110.3

838

3395

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

19.8

107.5

165

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

17.2

106.7

172

103

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

103.9

2192

14220

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

103.2

1159

5775

L86

ICPC

Back syndrome with radiating pain

3.7

102.2

485

1403

WX704

NOMESCO Finland

Intubation

3.3

101.6

569

1874

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

4.7

101.1

363

809

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

100.2

1302

6926

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.4

100.1

392

953

A02BC02

ATC

pantoprazole; systemic

1.9

99.4

3518

27212

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.8

97.8

694

2682

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

17.1

96.5

156

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

95.0

1722

10456

9183

FHL

Posterolateral spondylodesis

105.0

94.3

103

M03BX02

ATC

tizanidine; oral

1.8

93.3

3301

25222

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

91.9

613

2269

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.2

91.4

374

946

ZZH31

NOMESCO Finland

Bone allograft, small pieces

13.1

91.0

164

129

WX320

NOMESCO Finland

Spinalanesthesy

2.1

90.5

1349

7554

DLD00

NOMESCO Finland

Reconstruction of cartilage of nose

48.8

90.4

110

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.2

89.0

516

1735

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

4.5

88.9

332

768

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

88.0

561

2013

N02AC04

ATC

dextropropoxyphene; oral

4.3

87.8

350

863

M43.0

ICD-10 Finland

Spondylolysis

7.5

86.6

213

295

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.1

86.5

528

1839

ZXA05

NOMESCO Finland

Left side

2.0

86.0

1504

8936

M01AH01

ATC

celecoxib; oral (coxibs)

2.1

85.4

1128

5982

A02BC05

ATC

esomeprazole; systemic

1.8

85.0

2241

15354

S18

ICPC

Laceration/cut

1.8

84.9

2310

15990

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

3.0

84.2

522

1837

M54.1

ICD-10 Finland

Radiculopathy

4.1

83.9

348

890

L28

ICPC

Limited function/disability (L)

2.2

83.7

982

4933

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

83.2

613

2410

M01AB05

ATC

diclofenac; systemic, rectal

1.8

82.8

3544

28204

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

81.5

696

2977

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

12.7

80.0

146

118

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.5

79.7

707

3084

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.3

79.4

309

744

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.9

79.3

273

580

M54.3

ICD-10 Finland

Sciatica

3.2

79.2

461

1550

L17

ICPC

Foot/toe symptom/complaint

1.9

79.2

1410

8383

DJD20

NOMESCO Finland

Plastic repair of septum of nose

4.2

78.2

318

798

M95.8

ICD-10 Finland

Other specified acquired deformities of musculoskeletal system

769.5

77.5

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

24.9

77.4

110

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.2

76.8

431

1410

WX110

NOMESCO Finland

Local anesthesy

1.7

76.4

3518

28223

J01DB01

ATC

cefalexin; oral

1.9

76.3

4247

36244

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

75.7

1356

8056

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

75.5

1320

7773

N06AX11

ATC

mirtazapine; oral

1.8

75.1

1731

11219

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.4

74.9

390

1206

SPAT1153

SPAT

Removal of sutures

1.8

74.4

1795

11801

H02AB06

ATC

prednisolone; systemic

1.7

74.3

2491

18122

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.9

72.4

210

365

N05CF01

ATC

zopiclone; oral

1.8

72.0

1767

11651

A02BC03

ATC

lansoprazole; oral

1.8

71.6

1629

10476

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

71.5

2101

14631

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

71.5

1218

7079

WX402

NOMESCO Finland

General anaesthesia

2.1

71.1

949

5004

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

70.4

1848

12420

N03AE01

ATC

clonazepam; systemic

3.0

70.4

431

1498

M25.5

ICD-10 Finland

Pain in joint

1.8

69.4

1535

9757

WX002

NOMESCO Finland

Sedation and analgesia

2.0

69.1

1140

6536

ZXA00

NOMESCO Finland

Right side

1.8

68.5

1534

9784

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

67.5

721

3436

L13

ICPC

Hip symptom/complaint

2.1

67.3

915

4853

WX725

NOMESCO Finland

Noninvasive ventilation

3.3

67.0

358

1127

7397A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Upper extremities

+∞

66.8

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

5.4

66.1

206

391

A02BC01

ATC

omeprazole; systemic

1.8

64.2

1505

9694

M01AX17

ATC

nimesulide; oral

1.8

64.1

1373

8592

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.4

63.8

337

1052

M01AC06

ATC

meloxicam; systemic, rectal

1.7

63.6

1968

13775

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.2

63.4

178

297

J01FF01

ATC

clindamycin; systemic

1.8

62.4

1452

9315

NFJ64

NOMESCO Finland

Other internal fixation of fracture of other parts of femur

20.3

62.3

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

62.3

633

2939

R06.0

ICD-10 Finland

Dyspnoea

1.8

61.6

1344

8439

X58

ICD-10 Finland

Exposure to other specified factors

2.1

61.4

775

3970

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

61.0

645

3047

N06AX16

ATC

venlafaxine; oral

2.1

60.3

759

3880

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

60.0

632

2980

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

59.7

2271

16737

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.6

59.5

216

484

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

59.4

963

5443

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.4

59.0

300

909

R52.2

ICD-10 Finland

Other chronic pain

3.7

58.9

270

752

S72.3

ICD-10 Finland

Fracture of shaft of femur

9.5

58.8

124

134

M96.9

ICD-10 Finland

Postprocedural musculoskeletal disorder, unspecified

300.5

58.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

58.3

1556

10367

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

57.8

3109

24966

N05BA01

ATC

diazepam; systemic, rectal

2.1

57.7

776

4071

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

4.6

57.7

209

468

M01AH02

ATC

rofecoxib; oral

2.0

57.6

790

4179

M01AE02

ATC

naproxen; oral, rectal

1.6

57.4

2849

22393

7380A

ICD-9 Finland

Other acquired deformity, Acquired deformity of nose

+∞

57.4

R03AC02

ATC

salbutamol; inhalant

1.6

57.3

2629

20256

ZZG00

NOMESCO Finland

Graft of cartilage

37.0

57.0

WX702

NOMESCO Finland

Supraglottic ventilation device

2.9

56.4

361

1288

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

56.1

1518

10132

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

55.4

868

4831

M01AB55

ATC

diclofenac, combinations; oral

2.5

54.9

455

1894

WX212

NOMESCO Finland

Femoral plexus blockade

5.3

54.9

173

333

A06AD11

ATC

lactulose; oral

2.0

54.4

787

4244

NF3AA

NOMESCO Finland

Femur X-ray examination

5.0

54.4

181

370

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

5.5

54.2

167

313

A28

ICPC

Limited function/disability NOS

2.0

54.0

819

4500

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.6

53.9

255

729

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

53.8

4554

40926

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.9

53.7

183

384

1220

FHL

Arthroscopy

3.3

53.6

293

936

L08

ICPC

Shoulder symptom/complaint

1.8

53.1

1035

6218

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

52.5

1427

9494

AA1AD

NOMESCO Finland

CT of head and brain

1.7

52.2

1270

8180

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

5.8

51.6

151

266

7385A

ICD-9 Finland

Other acquired deformity of back or spine

+∞

51.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

51.1

1138

7123

J01MA02

ATC

ciprofloxacin; systemic

1.6

51.0

1974

14423

M02AA07

ATC

piroxicam; topical

1.6

50.9

1913

13873

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

50.2

688

3623

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

9.2

50.0

107

119

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

50.0

740

4016

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.8

49.9

337

1242

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.7

49.3

147

265

R4110

NOMESCO Finland

Physiotherapy

1.7

49.3

1388

9299

J01DA01

ATC

[U] cefalexin; systemic

1.5

47.9

3156

26006

A01

ICPC

Pain general/multiple sites

2.4

47.8

451

2004

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.4

47.4

242

734

WX400

NOMESCO Finland

Inhalation anesthesy

3.1

47.3

271

895

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

47.2

426

1852

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

47.1

3410

28654

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

47.1

928

5567

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

46.7

1070

6735

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

10.5

46.5

ZZH40

NOMESCO Finland

Substitute of bone

7.2

46.4

115

162

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

10.3

46.4

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

46.1

240

739

A02BA02

ATC

ranitidine; systemic

1.7

45.9

1048

6582

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

45.7

758

4279

WX720

NOMESCO Finland

Own respiration

3.1

45.7

266

886

L15

ICPC

Knee symptom/complaint

1.7

45.7

1073

6795

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.2

45.6

488

2305

N05BA04

ATC

oxazepam; oral

1.7

44.9

1242

8244

M53.2

ICD-10 Finland

Spinal instabilities

8.5

44.8

100

120

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.0

44.5

185

473

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

44.2

248

807

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

44.1

2673

21427

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

44.0

421

1881

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

43.9

263

895

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.8

43.9

194

524

R51.80

ICD-10 Finland

Headache

1.9

43.7

720

4053

J01AA02

ATC

doxycycline; systemic

1.6

42.6

3937

34520

M54.2

ICD-10 Finland

Cervicalgia

2.3

42.3

408

1831

TAB20

NOMESCO Finland

Epidural puncture

7.5

41.9

101

137

WZA90

NOMESCO Finland

Other doctors statement

1.7

41.9

1120

7339

N05AH04

ATC

quetiapine; oral

1.8

41.2

796

4724

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.5

41.0

340

1409

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

41.0

372

1618

SPAT1301

SPAT

No procedures

1.6

40.9

1569

11278

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.4

40.9

126

237

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.0

40.8

134

271

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

18.2

40.5

NF1DA

NOMESCO Finland

X-ray of hips

3.8

40.5

178

479

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.0

40.4

251

876

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

40.2

1394

9769

M01AX01

ATC

nabumetone; oral

2.7

40.1

290

1111

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

5.9

40.0

115

199

M95.9

ICD-10 Finland

Acquired deformity of musculoskeletal system, unspecified

+∞

39.6

M41.9

ICD-10 Finland

Scoliosis, unspecified

5.7

39.5

116

206

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

7.5

39.4

129

L12

ICPC

Hand/finger symptom/complaint

1.8

39.3

705

4077

L02

ICPC

Back symptom/complaint

2.1

39.2

466

2299

N06AB04

ATC

citalopram; systemic

1.7

38.8

1062

6985

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

7.9

38.6

116

J01FA06

ATC

roxithromycin; oral

1.5

38.1

1983

15203

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

8.5

37.9

100

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

37.8

596

3287

NH1AD

NOMESCO Finland

Ankle and foot CT

4.1

37.3

151

378

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

37.3

1225

8439

W19

ICD-10 Finland

Unspecified fall

2.0

37.2

490

2526

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

37.0

1340

9453

R02

ICPC

Shortness of breath/dyspnoea

1.9

36.9

615

3462

SPAT1263

SPAT

Sampling

1.5

36.7

2041

15828

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

36.7

1787

13476

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

36.6

254

950

N05CF02

ATC

zolpidem; oral

1.7

36.6

891

5658

R52.1

ICD-10 Finland

Chronic intractable pain

7.2

36.4

127

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

36.4

970

6317

N06AA10

ATC

nortriptyline; systemic

3.9

36.3

156

412

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

36.3

569

3132

N05CD07

ATC

temazepam; oral

1.8

36.1

663

3854

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

36.0

445

2230

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.9

35.6

152

399

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

35.6

2418

19485

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

35.5

2489

20179

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

8.0

35.4

102

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.2

35.3

192

612

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

35.3

263

1028

SPAT1229

SPAT

Assessment of need for aid

2.1

35.3

448

2271

WX214

NOMESCO Finland

Plexus blockade at the ankle

9.5

35.1

M01AB51

ATC

indometacin, combinations; oral, rectal

3.4

35.0

174

518

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

34.9

280

1140

R42

ICD-10 Finland

Dizziness and giddiness

1.6

34.9

1074

7259

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

34.6

218

768

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

34.6

1627

12141

ACC51

NOMESCO Finland

Release of median nerve

2.1

34.5

397

1930

NHG20

NOMESCO Finland

Fusion of talocrural joint

8.4

34.5

J01EA01

ATC

trimethoprim; systemic

1.6

34.5

1210

8443

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

51.6

34.4

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

6.2

34.2

154

C03CA01

ATC

furosemide; systemic

1.5

34.2

1366

9824

2309

FHL

Other measure in this category

34.1

34.0

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

33.9

371

1764

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.7

33.7

154

429

NHG22

NOMESCO Finland

Fusion of subtalar joint

7.2

33.4

115

R60.0

ICD-10 Finland

Localized oedema

1.9

33.4

564

3185

N06AB03

ATC

fluoxetine; oral

1.8

33.3

623

3641

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

4.6

33.0

118

262

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

32.8

2255

18106

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

26.7

32.7

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.6

32.2

239

931

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

32.1

541

3048

N03AX09

ATC

lamotrigine; oral

2.6

32.1

242

949

M01AX05

ATC

glucosamine; oral

1.6

32.1

1045

7143

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

31.7

578

3344

K02.1

ICD-10 Finland

Caries of dentine

1.4

31.7

2605

21576

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.0

31.6

104

212

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

31.6

1974

15525

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.3

31.5

304

1361

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

14.5

31.4

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

9.4

31.2

R53

ICD-10 Finland

Malaise and fatigue

1.6

31.2

972

6564

M79.7

ICD-10 Finland

Fibromyalgia

2.9

31.1

195

685

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.4

31.0

283

1234

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

31.0

375

1860

75618

ICD-8 Finland

Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae

14.6

30.9

L89

ICPC

Osteoarthrosis of hip

2.8

30.8

204

743

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

7.5

30.7

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.1

30.6

360

1766

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.3

30.6

158

486

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

30.2

354

1730

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.4

30.1

113

264

M54.8

ICD-10 Finland

Other dorsalgia

2.6

30.0

227

895

M54

ICD-10 Finland

Dorsalgia

1.8

29.9

540

3109

R06AE07

ATC

cetirizine; oral

1.4

29.9

2018

16054

NAG60

NOMESCO Finland

Anterior fusion of lumbar spine with fixation

41.3

29.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

29.6

832

5466

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

7.4

29.5

L04AA13

ATC

leflunomide; oral

3.0

29.5

172

577

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.0

29.4

177

606

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

29.3

535

3092

DHD10

NOMESCO Finland

Closed reduction of fracture of nose

8.1

29.2

7392A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Thoracic region

+∞

29.2

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

13.2

29.1

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

29.0

230

929

N07BC02

ATC

methadone; systemic

10.7

28.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

28.8

1426

10663

NG1DA

NOMESCO Finland

X-ray of knees

3.6

28.5

133

378

J02AC01

ATC

fluconazole; systemic

1.4

28.5

1800

14110

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

28.5

909

6164

M79.1

ICD-10 Finland

Myalgia

1.7

28.4

600

3633

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

28.4

1277

9357

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

28.4

667

4166

R01AD09

ATC

mometasone; nasal

1.4

28.3

2082

16773

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

28.2

373

1919

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.2

28.2

151

477

T84.2

ICD-10 Finland

Mechanical complication of internal fixation device of other bones

21.7

28.2

XA402

NOMESCO Finland

ENMG

3.0

28.1

167

566

M01AH03

ATC

valdecoxib; oral

2.1

28.1

348

1744

WX308

NOMESCO Finland

Sacral anesthesy

9.8

28.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

28.0

759

4928

SPAT1260

SPAT

Consultation of another employee

1.6

28.0

857

5746

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

28.0

298

1397

UKC02

NOMESCO Finland

Cystoscopy

1.6

27.9

765

4984

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

5.2

27.8

168

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

11.4

27.8

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

4.6

27.8

216

-1

NOMESCO Finland

1.4

27.7

1481

11225

J01CA04

ATC

amoxicillin; systemic

1.4

27.6

3873

34849

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.8

27.6

184

672

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

5.2

27.6

170

S29

ICPC

Skin symptom/complaint other

1.6

27.6

778

5109

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

5.9

27.5

134

Z50.1

ICD-10 Finland

Other physical therapy

2.2

27.4

295

1390

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

27.4

1206

8789

DHB50

NOMESCO Finland

Turbinoplasty

3.1

27.4

153

499

L14

ICPC

Leg/thigh symptom/complaint

2.0

27.3

365

1886

R01AD08

ATC

fluticasone; nasal

1.5

27.3

1295

9583

G04BD12

ATC

mirabegron; oral

1.8

27.1

500

2896

Z01.2

ICD-10 Finland

Dental examination

1.4

27.1

1853

14698

M99.4

ICD-10 Finland

Connective tissue stenosis of neural canal

+∞

27.1

J04AB02

ATC

rifampicin; systemic

4.6

27.0

213

RF210

NOMESCO Finland

2.9

26.9

173

619

Z71.8

ICD-10 Finland

Other specified counselling

1.5

26.9

1075

7666

R96

ICPC

Asthma

1.9

26.8

434

2404

B01AB04

ATC

dalteparin; parenteral

2.3

26.8

268

1221

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.6

26.8

206

818

ZXA10

NOMESCO Finland

Bilateral

1.6

26.8

881

6007

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

26.8

361

1868

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

26.7

280

1303

R35

ICD-10 Finland

Polyuria

2.1

26.7

322

1595

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

26.7

152

500

R05

ICPC

Cough

1.5

26.7

1013

7141

P01AB01

ATC

metronidazole; oral, rectal

1.4

26.7

1826

14479

KMAK

NOMESCO Finland

1.4

26.6

2371

19674

NAK30

NOMESCO Finland

Osteotomy of spine

45.9

26.5

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.8

26.4

173

625

P01BA02

ATC

hydroxychloroquine; oral

1.9

26.4

423

2336

UJF32

NOMESCO Finland

Coloscopy

1.5

26.2

1241

9167

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

5.7

26.1

135

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

26.1

2609

22032

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

9.4

26.1

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

9.4

26.1

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

4.4

26.0

226

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

25.8

380

2036

N06AB10

ATC

escitalopram; oral

1.5

25.6

868

5950

WX290

NOMESCO Finland

Other blockade of nerve

1.4

25.6

1904

15281

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

25.6

298

1451

J01MA12

ATC

levofloxacin; systemic

1.5

25.6

875

6015

C07AB07

ATC

bisoprolol; oral

1.4

25.6

2249

18571

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

25.5

823

5578

A02BA04

ATC

nizatidine; systemic

1.9

25.4

393

2144

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

25.4

325

1649

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.6

25.4

191

752

S21

ICPC

Skin texture symptom/complaint

1.7

25.4

586

3639

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

25.4

712

4660

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

4.7

25.3

187

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

25.2

1507

11625

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

25.2

739

4890

G44.2

ICD-10 Finland

Tension-type headache

1.7

25.1

595

3719

A46

ICD-10 Finland

Erysipelas

1.6

25.0

651

4175

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.8

25.0

162

584

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

25.0

654

4203

R52.9

ICD-10 Finland

Pain, unspecified

1.9

25.0

415

2322

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

24.9

214

904

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.7

24.9

173

650

S70.0

ICD-10 Finland

Contusion of hip

2.6

24.8

192

768

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

24.8

944

6647

N04BC05

ATC

pramipexole; oral

1.9

24.7

377

2043

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

24.7

389

2136

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

24.6

417

2348

L01

ICPC

Neck symptom/complaint

1.6

24.5

619

3937

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

24.5

344

1809

R33

ICD-10 Finland

Retention of urine

1.9

24.5

362

1941

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

24.5

413

2319

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

24.5

494

2943

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

24.5

405

2260

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.7

24.4

572

3563

D07AC01

ATC

betamethasone; topical

1.4

24.4

1566

12225

G04CA02

ATC

tamsulosin; oral

1.5

24.4

966

6854

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.5

24.4

116

336

N06AX03

ATC

mianserin; oral

2.2

24.3

256

1195

L16

ICPC

Ankle symptom/complaint

1.8

24.3

465

2727

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.9

24.2

116

S06.0

ICD-10 Finland

Concussion

1.8

24.2

474

2796

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.1

24.2

135

441

XKC03

NOMESCO Finland

Water cystometry

2.6

24.1

180

705

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.2

24.1

128

403

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

24.1

433

2485

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

4.2

24.1

220

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

7.9

24.1

S73.0

ICD-10 Finland

Dislocation of hip

6.5

24.1

Z98.1

ICD-10 Finland

Arthrodesis status

29.2

24.0

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

23.9

553

3430

G83.4

ICD-10 Finland

Cauda equina syndrome

8.9

23.9

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

3.7

23.9

107

295

XKD00

NOMESCO Finland

Uroflowmetry

1.6

23.8

711

4723

M03BX01

ATC

baclofen; systemic

3.5

23.8

112

322

A03FA02

ATC

cisapride; oral, rectal

1.9

23.6

389

2168

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

23.6

1953

15893

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

23.5

288

1436

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

23.4

887

6225

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

23.3

305

1563

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

23.2

249

1173

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

9.0

23.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

23.1

373

2064

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

23.1

252

1196

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

23.0

320

1678

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

23.0

355

1932

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.4

23.0

115

347

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

22.9

394

2229

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

22.9

640

4180

C07AA05

ATC

propranolol; systemic

1.5

22.8

865

6069

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

6.7

22.8

R4120

NOMESCO Finland

Occupational therapy

2.0

22.8

310

1612

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

22.7

449

2659

L88

ICPC

Rheumatoid/seropositive arthritis

2.3

22.7

208

909

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

22.7

239

1115

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

22.7

181

737

9165

FHL

Removal of osteosynthesis material

3.1

22.7

126

411

B01AF01

ATC

rivaroxaban; oral

1.6

22.7

564

3569

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

22.5

2003

16456

J01FA09

ATC

clarithromycin; systemic

1.4

22.5

1427

11078

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

22.5

342

1854

N05AA02

ATC

levomepromazine; systemic

2.3

22.5

212

940

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

5.8

22.4

112

P03

ICPC

Feeling depressed

1.9

22.1

361

2006

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.1

22.1

252

1219

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

22.1

501

3088

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

22.1

365

2039

S72.2

ICD-10 Finland

Subtrochanteric fracture

5.1

22.0

139

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

6.5

22.0

A01AB09

ATC

miconazole; local oral

1.8

21.9

421

2468

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

21.9

246

1182

7395A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Pelvic region

+∞

21.9

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

21.9

150

558

M01CB01

ATC

sodium aurothiomalate; parenteral

3.5

21.8

102

292

S97

ICPC

Chronic ulcer skin

2.1

21.7

265

1319

SPAT1216

SPAT

Assessment of functional ability

1.6

21.6

704

4766

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.9

21.6

131

453

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

21.6

578

3729

M99.7

ICD-10 Finland

Connective tissue and disc stenosis of intervertebral foramina

115.5

21.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

21.5

355

1980

L84

ICPC

Back syndrome without radiat pain

2.2

21.5

216

985

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

21.5

1270

9723

G47.3

ICD-10 Finland

Sleep apnoea

1.5

21.5

970

7053

N06AA12

ATC

doxepin; systemic

2.0

21.5

274

1388

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

5.9

21.4

103

R03BA02

ATC

budesonide; inhalant

1.5

21.1

774

5386

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.2

21.0

114

366

M01AE51

ATC

ibuprofen, combinations; systemic

3.3

21.0

108

334

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

20.9

2748

23845

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

20.8

1412

11064

A04

ICPC

Weakness/tiredness general

1.6

20.8

562

3630

M09AX01

ATC

hyaluronic acid; parenteral

2.0

20.8

265

1343

L29

ICPC

Musculoskeletal sympt/complt other

1.8

20.8

350

1964

B01AX06

ATC

[U] rivaroxaban; oral

2.7

20.7

143

536

R13

ICD-10 Finland

Dysphagia

1.9

20.7

303

1620

SPAT1262

SPAT

Handing over of treatment supplies

1.5

20.6

838

5959

J01FA10

ATC

azithromycin; systemic

1.3

20.5

2605

22465

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.8

20.5

134

486

N01

ICPC

Headache

1.8

20.5

389

2274

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

41.8

20.4

K30

ICD-10 Finland

Functional dyspepsia

1.7

20.4

480

2985

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

20.4

143

542

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.4

20.4

174

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

5.0

20.4

130

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

20.4

927

6742

WW502

NOMESCO Finland

Autotransfusion

6.0

20.3

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

20.3

293

1558

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

4.1

20.3

198

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

20.3

382

2223

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

20.2

1032

7679

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

20.2

202

922

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.5

20.2

158

636

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

20.1

119

406

S72.8

ICD-10 Finland

Fractures of other parts of femur

10.3

20.1

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.1

20.0

224

1076

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

5.9

20.0

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

20.0

221

7393A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Lumbar region

+∞

19.8

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

5.0

19.8

126

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

5.8

19.7

M02AA10

ATC

ketoprofen; topical

1.5

19.7

738

5156

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

19.6

342

1940

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

19.6

796

5655

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

19.6

557

3643

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

19.6

152

611

QBJ30

NOMESCO Finland

Correction of abdominal apron

5.7

19.5

UJD02

NOMESCO Finland

Gastroscopy

2.0

19.5

243

1221

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

19.5

304

1663

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

19.5

168

714

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

19.5

315

1743

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

19.4

19.5

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

11.3

19.4

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

19.4

112

376

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.1

19.4

109

360

A11

ICPC

Chest pain NOS

1.8

19.3

357

2065

E0000UV

ATC

1.3

19.3

1752

14342

RF120

NOMESCO Finland

3.8

19.3

213

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

6.0

19.3

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.7

19.3

143

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

19.3

589

3921

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

19.3

832

5985

ABA99

NOMESCO Finland

Other diagnostic operation on spinal cord or nerve root

31.4

19.2

SPAT1254

SPAT

Administration of medicine

1.5

19.2

661

4525

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.5

19.2

150

605

ZZH20

NOMESCO Finland

Graft of patients own bone

7.2

19.2

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

11.0

19.1

M41.8

ICD-10 Finland

Other forms of scoliosis

6.6

19.1

SPAT1240

SPAT

Therapeutic discussion

1.7

19.1

427

2619

M01AE52

ATC

naproxen and esomeprazole; oral

2.4

19.1

168

722

R21

ICPC

Throat symptom/complaint

1.5

19.1

743

5226

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

19.1

376

2221

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

19.0

169

728

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

4.4

18.9

155

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

18.9

120

429

NH1AI

NOMESCO Finland

Cone beam CT of ankle

8.4

18.9

R11

ICD-10 Finland

Nausea and vomiting

1.8

18.8

348

2015

R03DC03

ATC

montelukast; oral

1.5

18.7

685

4756

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

18.6

183

828

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.2

18.6

304

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

18.6

351

2048

NA8CB

NOMESCO Finland

Discography with X-ray

100.4

18.6

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.1

18.6

114

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

18.5

354

2071

M95.4

ICD-10 Finland

Acquired deformity of chest and rib

190.6

18.5

73799

ICD-8 Finland

Hallux valgus and varus

2.8

18.4

122

448

G56.4

ICD-10 Finland

Causalgia

7.5

18.3

M01AC01

ATC

piroxicam; systemic, rectal

1.5

18.3

640

4395

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

18.3

156

660

N03AF01

ATC

carbamazepine; oral, rectal

2.0

18.3

250

1305

SPAT1310

SPAT

Counselling related to known health issue

1.3

18.2

1427

11395

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.5

18.2

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

18.1

355

2096

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

9.3

18.1

SPAT1202

SPAT

Intra-articular injection

2.2

18.0

179

814

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

18.0

683

4775

7561A

ICD-9 Finland

Other congenital musculoskeletal anomalies, Anomalies of spine[SPONDYLOLISTHESIS CONGENITA]

33.0

17.9

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

5.2

17.9

106

D12

ICPC

Constipation

2.3

17.9

160

693

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3263

23070

1.92

127.58

5.1

4.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3848

29196

1.90

115.92

5.9

4.7

mmol/l

6.7

2.03

3654

27370

(3042936) Bacteria identified in Isolate by Culture

1315

7010

2.12

113.95

2.8

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

673

2717

2.67

109.95

8.3

10.1

—

(3003396) Base excess in Arterial blood by calculation

1119

5767

2.16

104.89

7.5

7.3

mmol/l

1.3

1.1

0.83

882

4466

(3002173) Hemoglobin [Mass/volume] in Arterial blood

974

4773

2.24

103.42

8.0

8.1

g/l

119.6

121.2

1.56

923

4598

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1105

5780

2.12

99.13

7.5

7.3

kpa

5.2

5.1

1.87

1047

5514

(3027801) Oxygen [Partial pressure] in Arterial blood

1104

5778

2.12

98.87

7.5

7.3

kpa

12.6

12.3

1.18

1048

5512

(3016502) Oxygen saturation in Arterial blood

1015

5159

2.17

97.96

7.7

96.1

95.7

1.71

973

4961

(3024561) Albumin [Mass/volume] in Serum or Plasma

2988

21711

1.76

95.62

5.7

4.9

g/l

35.0

35.4

3.74

2781

20140

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3093

22733

1.75

94.71

6.8

6.0

mmol/l

1.2

7.61

2861

20561

(3032080) INR in Blood by Coagulation assay

2837

20404

1.75

93.31

8.6

9.3

inr

1.2

1.3

4.45

799

5790

(3013707) Erythrocyte sedimentation rate by Westergren method

4476

36771

1.88

92.41

5.5

4.1

mm/h

12.9

12.5

0.95

4208

33995

(3031040) Bacteria [#/volume] in Urine by Automated count

4045

32420

1.78

88.17

6.0

4.6

e6/l

829.8

1972.8

1.36

443

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3293

25089

1.70

84.44

7.7

6.8

mmol/l

1.2

6.08

2815

21152

(3047181) Lactate [Moles/volume] in Blood

423

1584

2.80

79.20

6.4

mmol/l

1.2

1.3

1.29

382

1393

(3039000) Anion gap in Blood

340

1148

3.08

76.73

6.8

7.4

mmol/l

10.8

11.3

1.87

306

1028

(3018572) Chloride [Moles/volume] in Blood

340

1149

3.08

76.62

6.8

7.4

mmol/l

105.3

105.1

0.56

306

1029

(42870588) Differential panel, method unspecified - Blood

2367

16824

1.68

76.33

6.5

5.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4560

38494

1.79

75.92

8.6

7.6

u/l

78.8

78.5

0.15

4363

36200

(3037467) Urinalysis macro (dipstick) panel - Urine

4125

33919

1.71

74.68

5.8

4.4

—

(3023368) Bacteria identified in Blood by Culture

1992

13637

1.69

73.32

5.1

4.3

—

(3013115) Eosinophils [#/volume] in Blood

3269

25408

1.64

72.81

7.0

6.1

e9/l

0.2

0.54

2922

22225

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1546

9889

1.76

72.66

4.8

3.8

ng/l

297.2

482.8

0.89

1227

7814

(3007853) Bacteria identified in Skin by Aerobe culture

1033

5840

1.93

72.36

2.0

1.8

—

(3006315) Basophils [#/volume] in Blood

3178

24572

1.63

71.92

6.8

5.9

e9/l

0.0

0.32

2795

21141

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3326

26022

1.63

71.62

6.0

6.3

umol/l

10.8

11.4

2.66

3182

24677

(3001604) Monocytes [#/volume] in Blood

3160

24455

1.62

70.77

6.8

5.8

e9/l

0.6

1.66

2781

21045

(3022096) Basophils/100 leukocytes in Blood

2931

22282

1.62

70.51

7.0

6.1

0.7

1.20

2764

20721

(3006504) Eosinophils/100 leukocytes in Blood

2999

22943

1.62

70.18

7.0

6.1

2.9

0.20

2827

21318

(3019198) Lymphocytes [#/volume] in Blood

3227

25142

1.62

69.98

6.8

5.9

e9/l

1.9

0.65

2878

22053

(3019069) Monocytes/100 leukocytes in Blood

3010

23075

1.62

69.62

7.2

6.4

8.7

0.06

2851

21543

(3008152) Bicarbonate [Moles/volume] in Arterial blood

656

3186

2.19

69.49

8.1

6.8

mmol/l

24.9

24.6

1.39

605

2963

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

297

983

3.13

69.29

2.3

1.6

—

(3019060) Gas panel - Arterial blood

674

3340

2.15

67.76

5.7

4.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2202

15745

1.63

66.91

2.9

2.6

u/l

53.3

58.2

6.05

2054

14524

(3018418) pH of Serum or Plasma

2108

14946

1.64

66.05

4.1

7.4

0.35

362

2838

(3002030) Lymphocytes/100 leukocytes in Blood

3051

23656

1.60

65.83

7.1

6.2

27.5

27.6

0.28

2871

21948

(3018010) Neutrophils/100 leukocytes in Blood

3014

23328

1.59

65.32

6.9

6.0

57.6

57.5

0.20

2839

21735

(3013650) Neutrophils [#/volume] in Blood by Automated count

3530

28459

1.59

63.47

9.4

9.2

e9/l

4.2

4.1

2.64

3133

24808

(3035350) Ketones [Presence] in Urine by Test strip

3071

23979

1.58

63.29

4.4

3.7

estimate

0.0

0.80

575

4364

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1294

8148

1.75

62.92

2.1

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

972

5647

1.86

61.72

2.0

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2136

15421

1.60

60.86

2.5

2.2

u/l

223.6

217.5

0.08

2029

14438

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

220

660

3.42

60.21

7.7

6.7

mg/l

12.1

12.0

0.08

208

613

(3026008) Bacteria identified in Urine by Culture

2097

15107

1.60

60.10

4.1

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

963

5642

1.84

59.32

2.0

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

3083

24309

1.56

59.26

4.4

3.8

estimate

0.0

1.96

574

4320

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1781

12392

1.62

58.63

2.5

2.2

mg/l

2.8

3.0

2.33

1536

10572

(3021601) Nitrite [Presence] in Urine by Test strip

3046

24047

1.55

57.52

5.6

5.0

estimate

0.0

0.80

578

4451

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1297

8411

1.69

55.77

1.3

iu/ml

26.4

32.7

1.51

451

2609

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5383

49136

2.02

54.16

21.9

14.6

mg/l

23.7

24.0

0.31

4640

39156

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2649

20480

1.53

53.69

3.2

2.8

ug/l

125.3

135.1

1.52

2469

18884

(3044640) Blood type and Crossmatch panel - Blood

2132

15731

1.55

53.45

2.8

2.4

—

(3044889) 12 lead EKG panel

4120

35093

1.57

52.84

4.5

3.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2649

20602

1.52

51.45

2.3

2.0

pmol/l

94.4

95.7

0.70

1428

10570

(3000475) Leukocytes [#/volume] in Synovial fluid

305

1202

2.62

51.35

1.9

1.6

e6/l

13667.4

13030.9

0.06

222

863

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2156

16113

1.53

50.13

3.6

3.3

u/l

32.6

35.4

1.11

2062

15256

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1558

10879

1.59

48.81

1.9

1.7

mg/l

1.2

0.04

1276

8342

(3044941) Cell count panel - Synovial fluid

224

775

2.96

48.29

1.8

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1636

11593

1.57

47.93

1.7

1.5

nmol/l

21.0

20.6

0.24

1436

9877

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1206

7956

1.65

47.57

1.3

1.2

u/ml

13.8

12.6

0.20

401

3065

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

186

585

3.25

47.20

1.9

1.5

54.9

58.2

0.48

121

368

(3018095) Leukocytes [#/volume] in Urine

2288

17508

1.50

46.58

4.5

3.7

e6/l

86.0

104.5

0.51

1677

12448

(36304419) Bacteria [Presence] in Urine

1840

13456

1.53

46.47

3.7

3.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1180

7821

1.63

45.43

2.5

umol/l

12.4

12.9

1.76

1107

7235

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2597

20466

1.48

45.25

2.5

2.2

nmol/l

78.2

78.1

0.11

2368

18317

(3021788) Differential panel - Synovial fluid

237

878

2.77

45.03

1.9

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

2000

15040

1.50

43.56

3.9

3.3

e6/l

68.5

76.3

0.15

1569

11537

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

740

4370

1.79

43.41

3.2

2.9

ng/l

167.7

201.1

1.75

686

3974

(3014111) Lactate [Moles/volume] in Serum or Plasma

743

4395

1.79

43.34

6.9

7.0

mmol/l

1.3

1.30

712

4240

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

427

2099

2.11

43.18

6.3

5.3

1.8

1.6

3.67

392

1966

(3033658) Prothrombin time (PT) actual/Normal

1740

12752

1.52

42.74

4.7

4.0

91.0

89.8

1.20

1687

12444

(3007930) Methemoglobin/Hemoglobin.total in Blood

422

2087

2.10

41.97

6.4

5.4

1.0

0.9

3.66

387

1958

(3030467) Casts [#/volume] in Urine by Automated count

1853

13851

1.49

40.99

3.7

3.2

e6/l

0.5

0.4

0.29

1435

10420

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1085

7225

1.61

40.45

2.5

g/l

2.3

0.72

1016

6675

(3000850) Epithelial cells [#/volume] in Urine

1472

10516

1.53

40.33

2.8

2.6

e6/l

5.6

5.4

0.25

1320

9193

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1204

8233

1.58

40.09

3.5

3.4

mmol/l

0.8

0.39

1131

7676

(3019550) Sodium [Moles/volume] in Serum or Plasma

5460

50866

1.91

40.08

24.7

16.8

mmol/l

139.5

139.7

8.76

5391

49637

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1020

6732

1.62

39.33

2.5

2.6

21.0

22.6

3.14

813

5723

(3023103) Potassium [Moles/volume] in Serum or Plasma

5465

51021

1.89

38.47

24.8

17.0

mmol/l

4.0

3.30

5394

49701

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

302

1352

2.30

38.45

1.6

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

995

6579

1.62

37.95

1.4

1.3

titre

553.7

538.0

0.08

185

1384

(3002385) Erythrocyte distribution width [Ratio]

4520

40321

1.51

37.88

26.0

17.8

13.8

13.7

5.28

4454

39429

(3019150) Specific gravity of Urine by Refractometry

1459

10531

1.51

37.66

5.0

4.2

kg/l

1.0

0.72

224

1578

(3026782) Osmolality of Urine

1362

9730

1.52

36.79

3.1

2.8

mosm/kgh2o

521.7

543.7

3.49

1193

8265

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4261

37649

1.47

36.69

4.4

4.0

pmol/l

14.8

0.29

3926

34174

(3019309) Folate [Moles/volume] in Red Blood Cells

1326

9450

1.52

36.13

1.9

1.8

nmol/l

1169.6

1170.0

0.01

1049

7118

(3026493) Urate [Moles/volume] in Serum or Plasma

1758

13296

1.46

35.51

2.6

2.7

umol/l

2134.0

4830.3

3.42

1516

11469

(3003458) Phosphate [Moles/volume] in Serum or Plasma

973

6520

1.59

34.81

5.0

6.0

mmol/l

1.0

0.52

909

6057

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

478

2638

1.88

34.60

8.6

9.5

mmol/l

24.4

24.3

0.54

449

2465

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

615

3673

1.75

34.30

1.8

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1885

14574

1.43

33.35

3.2

3.0

ng/l

1406.2

1453.4

0.18

1635

12486

(3011397) Hemoglobin [Presence] in Urine by Test strip

1542

11493

1.46

33.19

4.3

3.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1118

7805

1.53

33.18

2.1

30.0

29.8

0.41

1072

7567

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1599

12017

1.45

32.90

2.7

2.3

—

(3000991) Gas panel - Venous blood

665

4117

1.69

32.48

8.2

8.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4909

44986

1.53

32.10

5.4

4.8

mu/l

1.8

2.1

3.31

4567

41098

(3036481) Cortisol [Moles/volume] in Serum or Plasma

706

4467

1.66

31.70

2.2

nmol/l

368.1

370.7

0.12

641

4085

(3014576) Chloride [Moles/volume] in Serum or Plasma

932

6308

1.57

31.66

7.9

7.0

mmol/l

104.4

0.16

895

6169

(40768797) Stomach Pathology biopsy report

1000

6914

1.54

30.79

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2132

17030

1.39

30.60

3.0

3.4

mmol/l

2.3

2.4

1.75

1884

14770

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1109

7919

1.49

29.12

3.6

3.0

e6/l

3.1

2.6

0.82

575

4289

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

177

4.28

29.01

2.0

ug/l

67.9

56.0

0.75

172

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2340

19110

1.37

28.82

4.5

3.7

ng/l

73.1

75.9

0.03

1644

13283

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1177

8527

1.47

28.70

3.2

2.8

e6/l

1.2

1.1

0.08

635

4868

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3674

32327

1.36

27.24

3.7

3.1

u/l

51.4

49.9

0.48

3463

30002

(3009508) Creatinine [Moles/volume] in Urine

1958

15665

1.37

26.93

3.1

3.2

mmol/l

7.4

0.04

1675

13117

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

833

5746

1.52

25.53

2.7

2.8

umol/l

7.3

8.2

0.62

710

4997

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2247

18482

1.35

25.46

4.8

4.0

—

(3026470) Cobalt [Mass/volume] in Blood

101

324

3.15

24.94

2.0

ug/l

3.7

3.2

0.32

283

(3029937) Albumin [Presence] in Urine by Test strip

1648

12950

1.38

24.92

5.3

4.2

estimate

0.0

0.39

570

4280

(3025577) Chromium [Mass/volume] in Blood

316

3.17

24.65

2.1

2.0

ug/l

2.0

2.4

0.57

265

(40758558) Short blood count panel - Blood

1597

12577

1.37

23.56

6.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1392

10746

1.39

23.16

1.8

1.7

pmol/l

42224594.4

29018542.0

0.34

1151

8891

(40761511) CBC panel - Blood by Automated count

5379

50990

1.58

23.02

20.4

13.7

—

(3048689) Calprotectin [Mass/mass] in Stool

808

5678

1.49

22.45

2.0

2.2

ug/g

148.6

141.4

0.16

652

4467

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3330

29321

1.31

22.08

3.0

2.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

330

1864

1.82

22.05

1.1

u/ml

1.0

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

794

5606

1.48

21.48

2.4

2.5

1.8

0.09

704

4962

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4896

45688

1.41

21.37

6.4

5.8

mmol/mol

40.0

39.9

0.14

4624

42189

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1332

10331

1.37

21.26

1.3

u/ml

1.8

1.9

0.07

321

2746

(3002032) Base excess in Venous blood by calculation

667

4581

1.51

20.61

3.5

3.8

mmol/l

2.1

2.0

0.42

539

3739

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1209

9280

1.38

20.47

2.8

3.1

mmol/l

2.4

2.5

1.04

1043

8113

(4010399)

540

3547

1.57

20.42

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

667

4591

1.51

20.39

3.5

3.8

kpa

5.9

5.8

1.40

642

4463

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

459

2915

1.62

19.99

1.5

—

(3021589) Normoblasts [#/volume] in Blood

2531

21666

1.29

19.94

11.7

9.7

e9/l

0.0

1.32

2078

17687

(3004588) Protein electrophoresis panel - Serum or Plasma

534

3534

1.56

19.52

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1595

12853

1.33

19.51

3.9

3.4

—

(3000494) Fungus identified in Specimen by Culture

814

5881

1.45

19.42

1.6

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1636

13242

1.32

19.37

1.8

1.6

mmol/l

1.4

1.17

1395

11095

(3012516) Albumin [Mass/volume] in Urine

1815

14909

1.31

19.33

3.1

3.2

mg/l

937.2

369.2

2.85

1170

9326

(36660697) Celiac disease serology panel - Serum

557

3733

1.54

19.24

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

618

4237

1.51

19.20

2.4

2.6

g/l

66.3

0.02

563

3853

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

382

2348

1.67

18.91

3.8

4.0

mmol/l

24.5

24.3

0.65

341

2121

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

134

3.98

18.82

1.6

1.2

35.6

32.4

0.22

(3023520) Reticulocytes [#/volume] in Blood

609

4196

1.50

18.45

2.5

e9/l

70.4

69.6

0.20

452

3156

(3034891) Synovial lining cells/100 cells in Synovial fluid

222

3.22

18.39

1.5

3.2

3.6

0.10

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

462

3002

1.58

18.26

7.0

7.1

mmol/l

25.0

24.8

0.60

457

2983

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

668

4699

1.47

18.26

2.7

2.4

u/l

36.5

48.6

0.58

573

4016

(3007164) IgA [Mass/volume] in Serum or Plasma

1166

9063

1.36

17.95

1.5

g/l

2.4

2.5

0.74

698

5511

(3003327) Ova and parasites identified in Stool by Light microscopy

266

1502

1.81

17.81

1.7

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

781

5685

1.43

17.79

3.6

4.3

u/l

240.0

244.6

0.49

732

5364

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

719

5171

1.44

17.47

4.4

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1878

15671

1.29

17.34

3.7

4.0

mg/mmol

10.5

9.6

0.32

1181

9809

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

111

457

2.46

17.21

1.8

1.4

26.6

30.7

0.58

280

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

460

3031

1.56

17.10

1.8

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

362

2278

1.63

16.34

1.7

g/l

1.6

0.12

309

1950

(3000570) Elastase.pancreatic [Mass/mass] in Stool

257

1478

1.77

16.20

1.5

1.4

ug/g

250.9

274.8

1.28

170

859

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

197

1044

1.92

16.14

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

197

1044

1.92

16.14

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

340

2116

1.64

16.04

1.7

1.6

u/ml

11.9

16.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

631

4505

1.45

15.88

6.1

7.7

mmol/l

10.1

10.0

0.08

600

4286

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

252

1461

1.76

15.46

2.2

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

4723

44397

1.31

15.25

24.1

15.7

39.5

39.7

0.99

3157

31412

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5446

52397

1.47

14.86

13.2

10.6

u/l

26.3

26.5

0.14

5322

50516

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

652

4744

1.42

14.76

2.1

2.2

g/l

0.2

0.60

603

4433

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

554

3918

1.46

14.62

3.4

3.8

ng/l

93.2

92.4

0.04

490

3336

(3010144) Erythrocytes [#/volume] in Synovial fluid

109

481

2.29

14.53

1.6

1.3

e6/l

98685.0

108181.6

0.06

335

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5042

47942

1.34

14.25

5.0

4.6

mmol/l

6.0

0.67

4645

43656

(46235355) HIV 1 and 2 tests - Meaningful Use set

904

6995

1.34

14.00

1.6

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

284

1750

1.65

13.95

2.5

2.3

ug/l

572.5

669.1

0.23

269

1649

(3020191) Ethanol [Moles/volume] in Serum or Plasma

384

2.42

13.93

2.3

1.4

promille

1.4

1.3

0.06

298

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

960

7501

1.33

13.91

1.6

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

741

5581

1.37

13.63

2.0

1.8

1.6

1.5

3.58

651

4896

(3052851) Hemolysis interference index of Serum or Plasma

249

1505

1.68

13.19

4.0

3.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

523

3731

1.44

13.16

2.9

2.7

g/l

9.9

10.5

2.99

486

3406

(3015171) Extractable nuclear Ab [Units/volume] in Serum

299

1907

1.60

12.80

1.3

1.2

u/ml

0.3

1.3

2.31

173

(3022217) INR in Platelet poor plasma by Coagulation assay

870

6779

1.33

12.77

22.0

25.0

inr

1.3

1.4

1.10

121

980

(3003338) MCHC [Mass/volume]

4405

41315

1.26

12.76

28.1

18.8

g/l

331.8

332.2

2.10

4376

41011

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

431

2986

1.48

12.63

3.1

3.3

pmol/l

4.5

4.4

0.15

385

2650

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

235

1417

1.69

12.57

2.3

2.5

g/l

3.8

3.6

1.35

224

1338

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

271

1697

1.63

12.52

2.8

2.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

422

2923

1.48

12.38

1.9

g/l

1.3

1.4

0.13

390

2666

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1883

1.59

12.37

2.1

2.4

g/l

3.1

0.02

225

1489

(3023419) Bacteria identified in Sputum by Culture

127

637

2.02

12.29

2.1

2.5

—

(3024928) Oxygen saturation in Venous blood

183

1036

1.79

12.25

3.0

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

517

3742

1.42

12.00

3.0

3.1

kpa

4.6

0.23

495

3626

(3006184) Hemoglobin [Mass/volume] in Capillary blood

192

1112

1.75

11.90

2.0

2.2

g/l

128.0

128.4

0.07

137

793

(3011288) Drugs identified in Urine by Screen method

155

842

1.86

11.87

4.1

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

310

2030

1.56

11.86

2.3

1.9

ug/l

2.1

2.3

0.07

273

1791

(3007461) Platelets [#/volume] in Blood

5594

54367

1.50

11.76

31.3

21.5

e9/l

253.2

250.2

2.76

5502

52987

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

233

1431

1.65

11.64

1.6

g/l

0.2

0.17

220

1351

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

306

2010

1.55

11.56

2.2

2.3

g/l

3.8

0.10

221

1455

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

306

2011

1.55

11.53

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

306

2013

1.55

11.48

2.2

2.3

g/l

7.5

0.12

228

1517

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

241

1499

1.63

11.46

1.4

1.3

—

(3035941) MCH [Entitic mass]

5594

54392

1.49

11.46

31.1

21.4

30.4

30.3

1.64

5549

53606

(3024731) MCV [Entitic volume]

5594

54393

1.49

11.45

31.1

21.4

91.4

91.2

5.15

5549

53610

(3026361) Erythrocytes [#/volume] in Blood

5594

54398

1.49

11.39

31.2

21.5

e12/l

4.4

4.5

18.49

5489

52850

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

151

826

1.85

11.33

1.3

—

(3010813) Leukocytes [#/volume] in Blood

5594

54408

1.48

11.27

31.3

21.5

e9/l

6.9

6.7

7.66

5487

52842

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

314

2087

1.53

11.25

1.6

1.9

u/l

39.7

39.1

0.22

278

1837

(3000963) Hemoglobin [Mass/volume] in Blood

5594

54411

1.48

11.23

31.5

21.6

g/l

133.2

135.2

19.95

5549

53628

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

292

2.45

11.18

1.8

1.5

u/l

5.3

6.7

0.96

249

(3025941) Bacteria identified in Stool by Culture

387

2690

1.47

11.16

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

238

1491

1.62

11.01

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

6.82

11.01

1.1

—

(3020891) Body temperature

304

2017

1.53

10.98

5.6

4.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

424

3022

1.43

10.71

3.0

3.3

g/l

128.4

128.6

0.09

411

2940

(3017704) Immunofixation for Urine

262

2.50

10.70

1.5

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

145

799

1.84

10.66

1.3

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

270

1760

1.56

10.57

3.1

3.0

u/ml

0.3

0.06

144

1004

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

252

1617

1.58

10.57

2.9

3.3

mg/l

28.9

56.6

2.46

203

1318

(3034860) Kappa light chains.free [Mass/volume] in Serum

252

1618

1.58

10.54

2.9

3.3

mg/l

263.9

56.6

0.45

205

1315

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

235

1484

1.61

10.54

1.5

1.6

g/l

1.2

0.68

222

1402

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

285

1882

1.54

10.53

2.2

2.3

g/l

10.2

0.06

235

1595

(3025159) Blasts/100 leukocytes in Blood

509

3766

1.38

10.38

4.2

0.8

0.3

0.29

113

930

(3037756) Immunofixation for Serum or Plasma

179

1059

1.71

10.34

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

189

1135

1.69

10.33

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

560

4219

1.36

10.20

4.1

4.2

1.0

0.9

0.16

140

1210

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

423

3045

1.42

10.12

1.4

1.3

au/ml

43.3

51.9

0.32

135

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

459

3354

1.40

10.08

2.5

2.4

au/ml

22.3

23.9

—

171

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

335

2314

1.47

9.99

2.7

2.8

1.4

1.2

2.11

335

2296

(3028707) Methadone [Presence] in Urine by Screen method

110

568

1.95

9.89

3.5

2.8

—

(3008898) HLA-B27 [Presence]

236

1520

1.58

9.76

1.0

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

513

3849

1.36

9.59

3.7

4.0

0.6

0.02

104

858

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

241

1571

1.56

9.47

2.9

3.3

ratio

2.7

2.1

0.19

123

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

255

1692

1.53

9.26

1.7

1.6

titre

126.0

303.7

1.46

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

579

4451

1.33

9.22

2.5

2.4

ug/l

7.7

7.5

0.03

502

3891

(3017143) Hepatitis C virus Ab [Presence] in Serum

646

5047

1.31

9.18

1.5

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

323

2259

1.45

9.06

2.7

0.6

0.7

0.65

303

2162

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.98

9.04

2.1

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

155

2.79

8.88

1.3

1.2

g/l

41.7

39.0

0.71

(40760892) CBC W Ordered Manual Differential panel - Blood

1255

10653

1.23

8.87

5.1

4.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

171

1050

1.65

8.65

2.7

2.9

umol/l

32.6

34.9

0.53

146

897

(1761868) Lipid panel - Serum or Plasma

1492

17085

0.83

8.50

2.9

—

(3036489) Thrombin time

267

1823

1.49

8.48

2.0

21.2

21.5

0.32

238

1589

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

507

1.93

8.48

3.2

3.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

523

4014

1.33

8.42

4.2

0.1

0.2

0.15

130

1122

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

393

2.05

8.33

1.2

1.1

—

27.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

161

985

1.65

8.28

3.0

2.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

228

1516

1.52

8.23

2.3

g/l

0.1

0.0

0.62

211

1395

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1715

1.49

8.15

2.4

g/l

0.7

0.9

0.79

223

1486

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1579

1.50

7.90

2.2

g/l

37.4

37.5

0.07

211

1364

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

187

1203

1.57

7.85

1.4

1.3

mg/l

549.0

532.7

0.12

182

1135

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

208

2.42

7.80

1.6

2.3

umol/l

85.2

143.0

1.03

113

(3014765) Yersinia sp identified in Stool by Organism specific culture

215

1430

1.52

7.78

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

213

1417

1.52

7.70

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

292

4053

0.71

7.66

1.7

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

396

2962

1.36

7.57

4.0

3.6

mmol/l

1.8

1.9

0.05

291

2191

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

167

1056

1.60

7.56

1.4

1.3

e6/l

13.1

24.3

0.63

133

812

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

370

2739

1.37

7.55

2.5

2.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

390

2913

1.36

7.53

1.4

1.3

u/ml

167.2

206.4

0.78

360

2678

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

167

1058

1.60

7.50

1.4

e6/l

593.8

1315.2

1.15

137

863

(3045414) Leukocytes [Presence] in Urine

318

2300

1.40

7.46

2.0

1.9

—

(3003181) Sodium [Moles/volume] in Urine

147

904

1.64

7.45

1.3

mmol/l

61.8

61.9

0.00

120

720

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

197

1301

1.53

7.38

1.6

2.0

mg/l

11.0

11.3

0.19

186

1202

(3022145) Colonoscopy Study observation

688

5573

1.27

7.35

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

214

1440

1.50

7.35

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

200

1329

1.52

7.29

1.5

1.4

iu/ml

16.7

15.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

205

1370

1.51

7.27

2.2

2.4

193.3

194.4

0.06

192

1305

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

161

1019

1.60

7.27

1.2

u/ml

1.2

5.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

192

1268

1.53

7.20

1.1

u/ml

13.3

8.2

0.23

144

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1414

1.50

7.19

2.3

g/l

0.0

0.00

193

1299

(3017446) Testosterone [Moles/volume] in Serum or Plasma

456

3513

1.32

7.16

2.6

2.2

nmol/l

12.7

12.9

0.19

401

3101

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

215

1465

1.49

6.96

1.6

iu/ml

0.6

4.6

0.51

315

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

206

1393

1.50

6.93

2.4

2.3

g/l

0.0

0.00

193

1298

(3024263) Appearance of Synovial fluid

292

2.10

6.87

2.2

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

183

1209

1.53

6.87

2.9

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

729

5992

1.25

6.85

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

129

785

1.66

6.85

1.4

1.6

g/l

0.7

0.8

0.94

594

(3016879) Cocaine [Presence] in Urine

178

1173

1.53

6.77

2.9

2.2

—

(3000492) Spirometry study

584

4687

1.27

6.73

1.5

—

(3009343) pH of Capillary blood

402

3073

1.33

6.68

4.0

3.6

7.4

0.67

378

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

407

3117

1.33

6.68

4.0

3.6

kpa

5.2

0.50

376

2875

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

131

807

1.64

6.64

1.6

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

221

1533

1.46

6.56

5.7

3.9

mmol/l

3.9

0.34

208

1435

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.81

6.52

1.3

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

162

1056

1.55

6.49

1.4

1.2

mmol/l

3.7

3.8

0.75

150

987

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

101

2.88

6.46

1.4

1.2

mg/l

134.3

69.4

0.18

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

541

1.77

6.43

1.2

u/l

60.3

59.0

0.08

368

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

178

1194

1.51

6.26

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

149

963

1.56

6.21

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

101

592

1.72

6.20

1.5

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

238

2.15

6.17

1.4

1.2

nmol/l

136.3

137.2

0.05

238

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

460

1.82

6.17

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

416

3238

1.31

6.10

1.9

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1763

15855

1.16

6.09

4.8

ug/l

2.3

3.2

2.21

1590

14252

(3022621) pH of Urine by Test strip

420

3274

1.30

6.09

3.6

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

197

1358

1.47

6.07

1.2

1.3

u/ml

12.0

38.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

114

695

1.65

6.06

1.1

1.3

nmol/l

0.6

2.3

0.52

106

665

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

459

3637

1.28

5.88

2.0

1.9

—

(4198724)

160

2.38

5.86

3.2

3.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

177

1204

1.48

5.84

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

103

618

1.68

5.83

1.1

1.3

nmol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

370

1.88

5.72

1.6

1.9

umol/l

7.9

8.1

0.02

258

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

162

2.35

5.71

1.1

1.2

—

(40761535) Cells panel - Urine sediment

517

4177

1.26

5.65

3.9

3.5

—

(3000764) Benzodiazepines [Presence] in Urine

183

1265

1.46

5.59

2.9

2.1

—

(44806118)

552

1.70

5.50

1.7

1.5

—

(44790047)

552

1.70

5.50

1.7

1.5

—

(44790049)

552

1.70

5.50

1.7

1.5

—

(44790048)

552

1.70

5.50

1.7

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

148

984

1.52

5.48

3.3

3.7

57.1

57.8

0.27

148

984

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5109

49713

1.20

5.41

5.4

5.0

mmol/l

2.7

2.8

8.42

4730

45719

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1423

12691

1.16

5.40

4.4

4.2

22.2

21.9

0.28

620

6086

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

180

1250

1.45

5.38

1.2

1.3

u/ml

10.1

5.4

—

126

(3028300) Cannabinoids [Presence] in Urine

183

1277

1.45

5.34

3.0

2.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.18

5.31

1.3

1.2

mmol/l

7.5

5.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

295

1.94

5.28

1.2

1.1

nmol/l

3.1

11.4

0.80

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

209

1499

1.41

5.25

2.1

94.3

90.8

1.51

195

1406

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

1265

1.44

5.24

1.2

1.3

u/ml

3.4

6.8

1.46

211

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

256

1900

1.36

5.24

2.1

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

169

1167

1.46

5.22

1.8

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

189

1334

1.43

5.20

2.0

1.8

nmol/l

40.3

41.3

0.25

184

1285

(21494755) Public health laboratory ask at order entry panel

323

4156

0.76

5.18

1.3

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.88

5.18

1.2

—

(3010421) pH of Blood

188

1330

1.43

5.11

4.3

7.4

0.27

161

1118

(3027944) Amphetamines [Presence] in Urine

178

1248

1.44

5.08

2.9

2.1

—

(3027008) Opiates [Presence] in Urine

181

1273

1.44

5.08

2.9

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

147

993

1.49

5.08

1.2

u/ml

40.1

44.1

0.13

110

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

111

705

1.59

5.07

1.1

1.3

nmol/l

0.4

0.3

—

(3049717) Cytology report of Urine Cyto stain

256

1911

1.35

5.06

2.6

—

(3012501) Base excess in Blood by calculation

164

1136

1.46

5.00

4.4

mmol/l

2.7

2.6

0.10

113

784

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

135

2.38

4.96

1.9

mg/l

9.8

9.6

0.05

108

(3044927) Protein electrophoresis panel - Urine

516

1.68

4.93

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

427

1.74

4.89

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

144

977

1.49

4.88

2.0

1.9

pmol/l

196.2

203.1

0.34

137

923

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5009

48742

1.18

4.86

4.7

4.5

mmol/l

4.6

4.7

7.17

4680

45065

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

503

4124

1.24

4.85

2.9

2.6

ml/min/173m2

64.4

65.0

0.15

213

1651

(3023511) Choriogonadotropin [Units/volume] in Urine

528

1.66

4.79

1.5

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

136

916

1.50

4.79

2.3

3.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

138

2.33

4.74

1.1

95.4

88.7

1.15

(4062490)

507

1.67

4.73

1.5

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

507

4173

1.24

4.72

3.7

3.9

mmol/l

1.2

0.18

443

3652

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

386

3080

1.27

4.72

1.2

iu/ml

104.6

142.7

1.48

158

1134

(3026389) Candida sp identified in Specimen by Organism specific culture

108

695

1.56

4.69

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

177

1261

1.42

4.66

2.9

3.2

mmol/l

24.4

24.9

0.95

155

1095

(3021879) Hepatitis B virus core Ab [Presence] in Serum

408

3289

1.26

4.59

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

506

1.65

4.51

1.5

1.3

g/l

6.3

6.8

0.71

359

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

328

1.81

4.45

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

499

4129

1.23

4.43

4.9

4.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

199

2678

0.73

4.41

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

204

1506

1.37

4.38

2.1

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

503

1.64

4.37

1.4

1.3

—

(3011985) Renin [Units/volume] in Plasma

103

668

1.55

4.35

1.5

1.4

mu/l

71.0

53.0

0.49

589

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

316

1.81

4.35

1.2

u/l

80.7

85.0

0.19

275

(3024139) IgG subclass 3 [Mass/volume] in Serum

505

1.63

4.31

1.5

1.4

g/l

0.4

0.19

357

(3028192) IgG subclass 2 [Mass/volume] in Serum

505

1.63

4.31

1.5

1.4

g/l

2.6

2.9

0.86

360

(3023410) Appearance of Cerebral spinal fluid

459

1.66

4.30

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

138

2.25

4.30

1.1

1.2

102.3

88.1

1.83

(3024869) Neuronal Ab [Presence] in Serum

2.59

4.29

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

101

2.48

4.28

1.1

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

384

1.73

4.28

1.2

1.5

u/ml

32.8

18.8

—

(3021901) Oxygen saturation in Capillary blood

132

906

1.47

4.28

2.3

2.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.74

4.25

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

370

1.74

4.25

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

304

1.82

4.24

1.9

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

139

2.24

4.23

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

319

1.79

4.23

1.5

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

371

1.73

4.21

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

189

1388

1.37

4.20

1.1

1.2

titre

66.5

161.7

1.18

112

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

328

1.78

4.16

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

149

1053

1.43

4.15

2.0

2.1

u/l

2504.6

4390.7

0.53

434

(3027273) Bicarbonate [Moles/volume] in Venous blood

303

2388

1.28

4.13

3.0

3.5

mmol/l

25.4

25.2

0.35

288

2315

(44816559) Phosphatidylethanol [Mass/volume] in Blood

124

847

1.47

4.13

1.5

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

457

1.65

4.12

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.72

4.11

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.72

4.11

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

374

1.72

4.11

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

404

3301

1.24

4.06

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

163

1178

1.39

4.01

2.4

2.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

347

1.74

4.00

3.2

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

303

1.79

3.99

1.2

u/l

21.6

20.9

0.07

258

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4960

48383

1.15

3.97

4.6

4.4

mmol/l

1.4

1.5

4.64

4598

44465

(1616796) Gas panel - Central venous blood

155

1113

1.40

3.96

3.9

3.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

152

1088

1.41

3.96

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

282

1.82

3.96

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

289

2279

1.28

3.94

1.4

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.13

3.92

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

298

1.79

3.90

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

623

1.53

3.87

1.2

1.3

pmol/l

285.0

320.8

0.29

480

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

121

836

1.46

3.83

1.7

1.2

u/l

45.9

40.8

0.11

112

728

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

300

1.77

3.82

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

636

1.52

3.74

1.1

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

244

1.85

3.73

1.4

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

149

1075

1.40

3.73

2.6

2.5

16.7

16.2

0.66

540

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

230

1.88

3.72

4.9

5.8

u/ml

72.3

668.0

—

(3008295) Osmolality of Serum or Plasma

518

1.57

3.70

1.2

1.4

mosm/kgh2o

278.5

278.4

0.01

391

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

112

768

1.47

3.70

1.6

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

116

801

1.46

3.70

2.1

1.9

mmol/l

1.7

0.07

111

781

(3000012) Reticulocyte production index

260

1.81

3.67

1.4

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

260

1.81

3.67

1.4

1.3

nmol/l

1.3

1.2

0.55

199

(1002224) Polysomnography panel

250

1955

1.29

3.66

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

367

3004

1.24

3.66

1.5

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

100

672

1.50

3.65

5.1

umol/l

350.2

361.9

0.33

581

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

162

2.04

3.64

1.1

1.2

g/l

0.3

0.09

127

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

197

1.93

3.61

1.7

1.5

umol/l

29.6

28.9

0.14

188

(3021387) Prolactin [Units/volume] in Serum or Plasma

177

1321

1.35

3.61

1.6

mu/l

325.6

299.6

0.58

161

1216

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

321

1.72

3.59

1.4

1.3

u/ml

1.6

0.6

0.34

148

(3008116) Ketones [Moles/volume] in Urine by Test strip

104

2.31

3.58

1.5

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

2.10

3.58

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

157

2.04

3.54

1.7

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

876

1.42

3.52

1.7

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

272

1.77

3.48

1.1

iu/ml

6.7

10.2

0.86

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

158

1166

1.36

3.48

1.7

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

132

2.13

3.44

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

263

2088

1.27

3.44

2.1

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

173

1.97

3.42

1.7

1.5

pmol/l

14.6

15.5

0.43

146

(40762814) Titanium [Mass/volume] in Blood

2.44

3.37

2.5

2.3

ug/l

2.6

4.1

—

(3016038) Potassium [Moles/volume] in Urine

328

1.68

3.35

1.3

1.2

mmol/l

31.4

34.9

0.65

278

(3045716) Anion gap in Serum or Plasma

239

1.80

3.33

4.4

2.3

mmol/l

8.3

9.3

0.51

188

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

201

1549

1.31

3.32

1.9

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.54

3.29

1.2

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

407

1.60

3.28

1.2

titre

209.0

186.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

213

1.84

3.21

2.5

2.2

umol/l

54.1

53.7

0.02

170

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

230

1.79

3.11

1.3

1.6

nmol/l

11.7

5.0

0.30

188

(40768443) Skin Pathology biopsy report

276

2233

1.25

3.10

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1082

0.66

3.09

3.9

3.5

mg/l

24.6

27.2

0.28

676

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

275

1.71

3.09

2.3

2.6

44.5

38.9

1.05

101

(3030981) Hyaline casts [#/volume] in Urine by Automated count

317

2606

1.23

3.08

3.3

2.8

e6/l

0.2

0.3

1.13

306

2539

(3042517) Benzodiazepines panel - Urine

3.24

3.05

2.5

2.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

384

1.59

3.04

1.5

1.3

mmol/l

2.1

0.12

357

(3003888) Timothy IgE Ab [Units/volume] in Serum

668

1.44

3.01

1.1

u/ml

3.3

4.5

0.39

312

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4767

46572

1.12

3.01

18.9

13.7

ml/min/173m2

80.4

79.6

1.78

4039

38571

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

121

878

1.39

3.00

1.8

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

521

1.50

3.00

4.2

3.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

241

1928

1.26

3.00

4.8

3.8

mmol/l

24.8

24.9

0.23

224

1766

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.01

2.98

1.0

2.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

127

2.05

2.96

1.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

671

1.44

2.95

1.6

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

264

1.71

2.95

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

148

1.96

2.94

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

334

1.62

2.90

1.8

1.7

—

(3045424) Erythrocytes [Presence] in Urine

119

868

1.38

2.88

1.6

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

162

1239

1.32

2.87

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

147

1113

1.33

2.81

1.3

1.4

u/l

11.7

10.7

0.34

116

907

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

738

1.40

2.78

1.3

1.2

u/ml

6.9

3.6

0.61

226

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

683

1.41

2.71

1.1

120.1

116.2

0.66

613

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

155

1190

1.31

2.70

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

214

1714

1.26

2.68

2.8

3.0

g/l

0.2

0.4

1.43

699

(3017732) Neutrophils [#/volume] in Blood

401

3422

1.18

2.67

2.8

3.0

e9/l

4.0

4.1

0.62

318

2626

(3016650) Hepatitis A virus Ab [Presence] in Serum

109

795

1.38

2.66

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

593

5221

1.15

2.65

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

696

1.40

2.62

1.8

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

174

1365

1.28

2.59

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

237

1.69

2.57

1.5

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

458

1.49

2.56

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.00

2.56

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

1.99

2.55

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.46

2.54

1.5

1.6

mmol/l

4.0

4.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

525

1.45

2.53

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

484

1.47

2.53

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

882

1.34

2.49

1.8

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

938

0.68

2.49

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.38

2.46

2.9

2.8

—

(3022313) Gas panel - Capillary blood

270

2242

1.21

2.44

4.5

3.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

264

1.63

2.43

2.0

2.1

ug/min

93.9

219.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

327

1.56

2.42

1.7

1.6

u/l

4.9

6.2

0.26

154

(21494890) Protein electrophoresis panel - 24 hour Urine

523

1.44

2.40

2.1

2.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.34

2.39

1.0

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.11

2.38

1.4

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

483

1.45

2.37

2.7

2.8

—

(3019977) pH of Arterial blood

290

1.59

2.35

3.1

2.8

7.4

1.78

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.50

2.35

2.2

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.50

2.35

1.6

umol/l

50.3

41.7

0.50

(3011648) Oxygen content in Venous blood

402

1.50

2.35

2.0

2.1

10.7

11.0

0.19

402

(4281824)

563

0.60

2.33

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

510

1.44

2.32

1.1

—

3.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

420

1.48

2.31

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

420

1.48

2.31

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

420

1.48

2.31

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

105

2.00

2.30

1.1

umol/24h

0.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

1.81

2.29

2.1

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

1.81

2.29

2.1

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

234

1930

1.22

2.29

2.0

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

340

1.53

2.29

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

604

1.40

2.28

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.56

2.26

1.3

ug/l

41.6

128.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

224

1842

1.22

2.26

2.6

3.5

u/ml

529.3

3066.8

0.96

191

1567

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

262

1.61

2.25

1.3

1.1

u/l

26.9

28.1

0.06

191

(40768804) Tissue Pathology biopsy report

2144

20373

1.08

2.24

2.2

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.10

2.22

1.4

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

128

1.88

2.20

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

151

1191

1.27

2.20

1.9

1.8

iu/l

4.3

4.7

0.16

430

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

256

1.61

2.20

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.78

2.20

1.5

2.5

—

(3020491) Glucose [Moles/volume] in Blood

368

1.50

2.19

2.2

2.1

mmol/l

7.1

6.8

0.47

242

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

241

1.62

2.18

1.3

46.3

59.4

—

(3022689) Creatine [Moles/volume] in Urine

151

1.79

2.15

1.7

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

330

1.52

2.13

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

648

1.36

2.10

1.1

u/ml

0.9

1.2

0.21

256

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.45

2.10

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

261

1.57

2.05

3.1

4.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.50

2.05

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

317

1.52

2.05

1.2

1.3

—

60.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

358

1.48

2.04

1.2

1.1

mg/l

36.5

41.1

0.62

295

(3048929) Epstein Barr virus Ab [Presence] in Serum

163

1312

1.25

2.03

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

147

1.77

2.02

2.7

2.9

mg/l

5.8

7.2

0.74

117

(3004451) EKG impression Narrative

255

1.57

2.00

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

155

1.75

1.99

1.3

2.1

165.1

181.3

0.33

144

(4034850)

196

1615

1.22

1.98

13.4

9.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

981

1.28

1.94

4.9

5.7

iu/ml

672.6

2170.9

0.44

137

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.55

1.94

3.8

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

2.57

1.92

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

1.78

1.90

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

108

1386

0.78

1.89

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

128

1.80

1.89

1.7

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

448

1.41

1.88

1.6

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

316

1.49

1.87

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

508

1.38

1.86

1.1

97.3

95.3

0.24

477

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

317

1.49

1.85

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

274

2348

1.18

1.83

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

1.77

1.81

1.2

1.1

—

(4015189)

130

1.77

1.81

2.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.27

1.80

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.27

1.80

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

352

1.45

1.80

1.1

1.0

ng/l

752.9

724.5

0.15

236

(3033705) Calcium.ionized [Moles/volume] in Venous blood

608

0.67

1.79

2.1

2.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

263

1.52

1.78

1.3

1.1

u/l

98.2

87.7

0.47

198

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.34

1.77

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

561

6202

0.89

1.76

4.7

4.6

31.6

32.5

1.11

410

4135

(3042631) Mycobacterium sp identified in Specimen

695

1.31

1.76

2.2

2.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

127

1013

1.26

1.76

3.4

3.1

nmol/l

0.8

0.37

103

772

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

574

1.35

1.75

1.8

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

124

1.78

1.75

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

498

1.37

1.73

3.3

3.1

mg/l

43.2

46.8

0.04

373

(3004775) Volume in Urine collected for unspecified duration

398

0.60

1.73

2.9

2.2

802.0

624.6

0.78

266

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

355

1.44

1.73

1.1

1.0

ng/l

34.9

45.0

1.25

241

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

767

1.30

1.73

1.2

1.1

u/ml

1.3

1.6

0.27

288

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

217

1.57

1.73

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

347

1.44

1.72

1.2

1.1

mg/l

275.8

275.7

0.00

297

(4306422)

715

1.31

1.72

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

250

1.52

1.70

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

250

1.52

1.70

1.1

1.5

—

(3006462) Nitrate [Presence] in Urine

226

1.55

1.70

3.7

—

(3051593) INR in Capillary blood by Coagulation assay

242

1.53

1.70

9.7

11.4

—

(3002256) Pathology report gross observation

712

6526

1.10

1.69

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

192

2280

0.84

1.67

1.8

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

172

1.63

1.66

1.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

621

0.69

1.66

2.0

2.3

mmol/l

4.1

0.00

611

(3035285) Chloride [Moles/volume] in Venous blood

621

0.69

1.66

2.0

2.3

mmol/l

106.1

105.4

0.52

611

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.58

1.65

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.58

1.65

1.0

—

(3045788) Cell count panel - Pleural fluid

477

1.37

1.65

1.4

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.10

1.65

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

720

1.30

1.65

1.3

1.2

u/ml

4.9

4.3

0.20

295

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.93

1.64

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

352

1.42

1.62

1.1

1.0

ng/l

259.7

329.1

1.29

243

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.33

1.60

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.59

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

151

1.66

1.59

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

251

2167

1.17

1.57

1.2

1.1

titre

172.0

163.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

551

1.33

1.56

3.2

17.8

mmol/l

8.8

7.4

0.37

459

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

337

0.59

1.56

1.3

1.5

ug/l

2.2

4.2

1.13

272

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

137

1.68

1.54

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

509

1.34

1.54

2.3

3.5

62.7

57.7

1.27

320

(3014271) Vancomycin [Susceptibility]

273

1.47

1.53

3.1

2.9

—

(4211845)

249

1.49

1.52

3.6

—

(44806420)

140

0.43

1.51

2.2

2.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

266

1.47

1.50

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.16

1.50

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

705

1.28

1.49

1.7

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

444

1.35

1.48

4.1

5.0

u/ml

120.2

63.4

0.33

128

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

187

1.55

1.45

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

187

1.55

1.45

1.7

1.9

—

(3014891) Appearance of Pleural fluid

1.92

1.43

1.4

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

438

1.35

1.43

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

404

1.36

1.43

1.1

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

106

853

1.25

1.42

1.3

1.4

u/ml

126.3

117.8

0.23

178

(3010726) Horse dander IgE Ab [Units/volume] in Serum

596

1.30

1.41

1.1

u/ml

1.2

2.5

0.87

136

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

189

1.54

1.39

1.7

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

372

1.37

1.39

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1791

1.17

1.38

1.7

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

528

1.31

1.38

1.9

1.8

titre

413.3

901.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.2

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.61

1.36

10.8

10.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

331

1.39

1.36

2.0

2.4

e6/l

962.0

656.4

0.53

137

(1617658) Protocol used for examination of sentinel lymph nodes

396

0.66

1.36

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

391

1.36

1.35

1.2

—

75.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

223

1.48

1.35

1.1

1.0

u/ml

0.5

3.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

100

805

1.25

1.35

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

199

1.51

1.34

3.1

2.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

104

843

1.24

1.32

2.5

3.6

1.6

1.5

0.07

648

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

116

952

1.22

1.32

1.3

1.4

—

(3036603) Volume of Urine

342

1.38

1.31

1.8

1.5

2298.5

1842.9

0.64

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

242

1.45

1.29

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

242

1.45

1.29

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

242

1.45

1.29

1.6

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

412

3731

1.11

1.29

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

193

0.52

1.29

1.3

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

605

1.28

1.4

1.5

e6/l

2024.6

2130.2

0.08

437

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4742

46774

1.07

1.28

4.2

4.0

mmol/l

1.4

1.3

7.00

4373

42643

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.89

1.28

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.89

1.28

1.5

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.72

1.27

1.0

1.2

mmol/l

1.6

1.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.29

1.26

1.0

1.1

—

(44813793)

311

1.39

1.25

1.1

—

(3028433) Virus identified in Specimen by Culture

170

1.53

1.25

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

528

1.29

1.25

2.8

4.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

406

1.33

1.24

1.6

2.2

48.7

42.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.40

1.24

1.5

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.40

1.24

1.3

1.4

pmol/l

12.3

28.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.22

1.24

1.0

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.22

1.24

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

253

1.43

1.23

2.1

1.7

u/field

2.8

0.00

176

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.31

1.18

1.0

1.4

umol/l

1.2

0.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

480

1.29

1.18

1.0

1.1

u/ml

1.8

3.3

1.07

182

(3051651) Icteric interference index of Serum or Plasma

307

1.37

1.17

5.0

3.5

—

(4027681)

273

1.39

1.17

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

224

0.58

1.16

1.2

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

1.15

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.15

0.0

3.5

—

0.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

1.15

0.0

3.0

—

(3013512) EKG study

1528

14647

1.06

1.14

4.1

4.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

589

1.26

1.14

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.33

1.12

1.4

1.5

umol/24h

365.6

365.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.6

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.96

1.11

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

243

1.40

1.09

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

801

1.21

1.08

1.2

1.1

—

(4133840)

112

1.61

1.08

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.19

1.08

1.1

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

630

1.24

1.07

1.1

u/ml

1.4

3.2

2.13

277

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.07

1.1

—

(40768793) Breast Pathology biopsy report

1134

0.83

1.07

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

287

1.36

1.06

1.2

1.1

ratio

1.1

1.0

0.10

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

105

877

1.20

1.05

1.2

u/ml

305.5

286.7

0.13

557

(3023323) Follitropin [Units/volume] in Serum or Plasma

207

1826

1.14

1.05

1.4

1.3

iu/l

31.1

32.3

0.20

184

1563

(1761482) Bacteria [#/volume] in Urine by Culture

107

1273

0.84

1.05

4.1

4.4

—

(3047189) Immunofixation for 24 hour Urine

245

1.39

1.05

2.1

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

678

1.23

1.04

1.3

1.5

g/l

31.8

32.4

0.16

614

(3046861) Legionella sp Ag [Presence] in Urine

2.27

1.03

1.2

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.96

1.03

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.73

1.02

2.7

2.2

umol/l

15.9

17.6

0.28

(3021162) Amylase [Enzymatic activity/volume] in Specimen

107

0.47

1.00

6.4

2.9

u/l

87.2

1777.9

—

102

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

274

0.66

1.00

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

115

1.57

0.99

1.2

2.0

e6/l

210.0

167.5

0.21

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

132

0.53

0.98

1.1

—

(3045142) Bone marrow Pathology biopsy report

575

1.24

0.98

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

159

0.57

0.98

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

181

1.44

0.98

1.7

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

160

0.56

0.97

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.97

0.0

3.0

—

(4035726)

416

4510

0.92

0.97

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

108

913

1.19

0.97

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

540

1.24

0.97

1.3

1.5

e6/l

29036.5

70018.1

1.41

311

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.80

0.96

1.1

umol/24h

1.6

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.74

0.96

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

713

1.21

0.95

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

306

0.69

0.95

1.1

1.3

—

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.77

0.94

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

965

0.83

0.94

1.1

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

117

1.54

0.93

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

1.54

0.93

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

634

1.22

0.92

2.3

2.1

mg/l

30.1

22.8

0.46

160

(3026250) Tacrolimus [Mass/volume] in Blood

220

0.64

0.91

49.6

34.5

ug/l

7.9

7.4

0.39

201

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.67

0.91

1.0

1.3

mmol/l

1.0

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

349

1.29

0.90

1.2

1.3

u/l

15.5

13.1

0.34

321

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

774

1.19

0.89

2.0

2.7

u/ml

317.4

1467.4

—

(4268621)

492

1.24

0.89

2.3

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

412

1.26

0.88

1.7

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

119

1.51

0.88

1.4

1.1

pmol/l

402.8

320.4

0.19

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

1.53

0.87

5.4

7.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

1.55

0.87

1.3

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.00

0.87

1.5

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

769

1.19

0.85

1.3

—

(40757373) Influenza virus identified in Isolate

112

1.52

0.84

1.6

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

145

1.45

0.84

1.8

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.78

0.84

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.76

0.83

1.8

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.76

0.83

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

134

1175

1.14

0.80

1.3

miu/ml

178.7

214.6

0.42

526

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

747

7095

1.06

0.80

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

642

0.81

0.80

1.6

1.5

—

(40758358) Immune stain study

0.00

0.79

0.0

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

0.79

0.0

1.1

—

0.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

207

1.35

0.79

2.8

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

670

6346

1.06

0.79

9.7

7.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

106

1.51

0.78

1.1

u/ml

0.1

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

216

1.34

0.78

1.1

1.0

u/ml

0.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.56

0.78

6.2

7.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

111

963

1.16

0.77

2.3

1.8

nmol/l

0.9

0.8

0.26

802

(3007916) DNA double strand Ab [Titer] in Serum

1.67

0.74

1.1

1.2

—

64.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

523

1.21

0.74

1.1

u/ml

5.2

2.3

0.54

190

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

219

1.33

0.73

1.0

89.5

94.6

0.37

167

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

653

1.18

0.72

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.72

1.2

1.0

—

(3042733) HLA Ab [Presence] in Serum

159

0.63

0.72

2.5

5.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

621

0.82

0.71

1.2

mmol/l

6.9

7.4

0.48

463

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

291

1.27

0.70

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

126

1.43

0.70

5.1

7.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.71

0.70

1.1

2.1

—

(3012441) Differential panel - Pleural fluid

518

1.20

0.69

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

647

1.18

0.69

1.7

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

230

1.31

0.69

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

629

1.18

0.69

1.7

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.53

0.68

1.5

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

565

1.19

0.68

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

0.68

5.1

4.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.2

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.63

0.66

1.0

1.2

u/l

5.0

17.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.79

0.66

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

312

1.25

0.66

5.8

6.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

632

1.17

0.66

1.7

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.57

0.65

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.46

0.64

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

198

1.31

0.63

1.1

ng/l

22.6

406.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

635

1.17

0.63

1.7

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

691

1.16

0.63

1.9

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

600

0.83

0.62

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.55

0.62

1.3

1.2

ng/l

48.5

66.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.55

0.62

1.1

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.63

0.62

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

599

0.83

0.61

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

599

0.83

0.61

1.4

—

(21494434) Karyotype in Bone marrow

443

1.20

0.61

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

600

1.17

0.61

1.5

1.3

u/l

33.0

30.1

0.29

483

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.60

0.61

1.4

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

598

0.83

0.61

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

629

1.16

0.60

1.7

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.53

0.59

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

162

0.68

0.58

2.4

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

520

1.17

0.58

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

382

1.21

0.57

1.9

1.7

—

(3016228) CD19 cells/100 cells in Blood

219

0.73

0.57

1.6

2.0

8.3

8.4

0.03

209

(3011412) CD3 cells [#/volume] in Blood

475

1.18

0.56

1.9

2.3

e9/l

1.2

1.1

0.21

294

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

239

1.26

0.55

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

239

1.26

0.55

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

105

936

1.12

0.55

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

635

1.15

0.55

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

431

1.18

0.54

1.1

—

(3025315) Body weight

1.58

0.54

6.3

4.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

142

1.34

0.54

2.3

2.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

204

1.28

0.54

2.4

5.2

mg/l

59.1

62.5

0.13

143

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.49

0.53

1.9

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.54

0.53

5.5

3.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

638

1.15

0.52

1.7

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

232

1.25

0.52

2.2

2.5

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.50

0.51

2.2

1.9

mg/l

1.8

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.50

0.51

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

508

1.16

0.51

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

109

1.38

0.50

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.41

0.50

1.7

1.8

ng/l

100.7

140.8

0.61

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

379

0.82

0.50

2.0

1.5

g/l

0.9

1.0

0.17

379

(3008536) Aspergillus sp Ab [Presence] in Serum

101

1.39

0.49

1.8

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.43

0.49

2.9

2.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.56

0.48

1.4

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

235

1.24

0.48

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

226

1.24

0.48

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

137

1.31

0.47

1.8

1.6

ug/l

0.5

0.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

177

0.73

0.47

1.7

2.0

—

(3024932) HLA-DR beta [Type]

154

0.71

0.47

1.1

—

(4024509)

504

1.15

0.46

1.4

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

173

1.27

0.46

1.5

1.3

75.1

54.1

2.19

145

(3044242) Glucose [Moles/volume] in Arterial blood

255

1.22

0.45

2.7

2.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

209

0.76

0.45

1.6

2.0

—

(37021550) Renin [Units/volume] in Plasma --upright

112

1.34

0.44

1.3

mu/l

40.4

70.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

142

1306

1.09

0.44

3.2

3.1

mg/l

1.6

0.05

126

1195

(40761539) Cells [Type] in Urine sediment by Light microscopy

130

1.31

0.43

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.61

0.43

4.0

8.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.61

0.43

1.2

1.0

—

(40768441) Liver Pathology biopsy report

368

1.17

0.42

1.5

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

131

1.30

0.42

1.4

1.2

ug/l

3.9

359.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.38

0.41

2.3

1.8

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

277

1.19

0.41

1.1

—

(3006270) Folate [Moles/volume] in Blood

454

1.15

0.41

1.3

1.2

nmol/l

356.4

353.6

0.03

387

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

1.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.41

0.39

1.7

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

1.0

—

(3024471) HLA-A [Type]

159

0.75

0.38

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.39

0.38

1.0

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.39

0.38

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

197

1.22

0.37

1.1

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.32

0.37

19.0

12.9

mmol/l

8.7

6.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.35

0.37

1.0

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

1.29

0.37

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

246

0.81

0.37

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.36

0.36

1.0

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.36

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.36

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.36

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

480

0.87

0.35

1.2

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

172

1.22

0.34

1.3

2.2

—

19506.9

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.33

0.33

1.0

—

16.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.32

0.33

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

758

1.10

0.33

1.1

iu/ml

16.9

13634.7

0.54

172

(3036782) Glucose [Moles/volume] in Pleural fluid

472

1.12

0.33

1.2

1.4

mmol/l

6.5

6.4

0.05

440

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

105

1134

0.92

0.32

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.28

0.32

3.3

2.5

u/field

0.2

0.6

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.35

0.31

1.4

pmol/l

4.3

15.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

259

1.16

0.29

1.1

u/l

1.1

0.41

140

(3002523) Influenza virus A Ag [Presence] in Specimen

649

1.10

0.29

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

363

1.13

0.29

1.6

2.0

—

(3019225) pH of Specimen

495

5102

0.97

0.29

4.6

4.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.25

0.27

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.23

0.27

2.3

2.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

225

1.16

0.26

1.2

1.1

u/ml

13.5

25.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

159

1673

0.95

0.25

1.7

mg/l

4.5

3.9

0.28

122

1198

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

188

1.17

0.25

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

675

1.08

0.25

1.1

g/l

1.6

1.5

0.57

608

(3050129) First trimester maternal screen panel - Serum or Plasma

746

0.92

0.24

1.2

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

180

0.83

0.24

1.3

1.5

mmol/l

9.2

8.3

—

105

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

379

1.11

0.23

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

115

1.22

0.23

1.1

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

168

0.83

0.22

1.9

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

285

1.12

0.22

1.8

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

641

1.08

0.22

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

651

1.08

0.22

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

172

1.16

0.22

2.7

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

116

1.21

0.22

2.9

2.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

554

5416

1.03

0.21

3.0

4.0

ug/l

40.9

25.1

0.32

456

4391

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

372

1.10

0.21

1.6

2.0

14.5

14.2

0.05

159

(3019174) dRVVT (LA screen)

1.19

0.21

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.19

0.21

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

90.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3012898) Urea [Moles/volume] in Urine

1.16

0.21

1.8

1.2

mmol/l

217.2

156.4

—

(3000330) Specific gravity of Urine by Test strip

264

2554

1.04

0.20

3.2

3.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

11541.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

155

1.16

0.19

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

127

1211

1.05

0.19

2.4

2.3

ug/min

75.9

110.8

0.93

737

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.22

0.19

1.1

pmol/l

—

5.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.15

0.19

1.0

1.2

—

(3001729) Color of Synovial fluid

1.13

0.18

2.3

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

467

0.92

0.18

1.4

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

100

1.20

0.18

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

119

1244

0.96

0.17

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

465

1.08

0.17

1.5

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.72

0.16

4.0

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.72

0.16

2.0

2.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.75

0.15

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

390

1.08

0.15

1.3

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

265

1.09

0.14

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

511

0.94

0.14

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

431

1.07

0.14

1.1

1.0

u/ml

0.2

0.4

0.52

101

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

141

1.14

0.13

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

572

0.94

0.13

1.3

1.4

nmol/l

0.3

0.4

1.05

435

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

151

1.13

0.13

1.6

ug/l

8.6

8.8

0.04

151

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

286

1.08

0.13

1.9

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

549

1.06

0.13

1.3

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

232

0.90

0.13

1.7

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

161

1.12

0.13

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.14

0.12

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

262

2569

1.02

0.11

2.5

3.7

u/ml

84.1

58.9

0.22

252

2468

(4094501)

138

1416

0.97

0.09

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

207

0.92

0.09

1.1

u/ml

8.0

5.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.11

0.09

1.8

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

194

1.08

0.09

1.1

miu/ml

1520.1

1543.3

0.03

194

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

1487

1.02

0.08

1.2

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

144

0.90

0.08

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.83

0.07

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

500

0.96

0.07

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

398

0.95

0.07

2.3

2.0

u/field

1.9

2.0

0.06

154

(3041806) Other cells [#/volume] in Blood by Manual count

1.03

0.07

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

167

1.08

0.06

1.7

2.6

umol/l

32.0

28.8

0.51

119

(3034426) Prothrombin time (PT)

167

1.08

0.06

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

183

0.93

0.06

1.6

2.2

e6/l

335.4

827.4

—

128

(3048879) Bone marrow aspiration report

138

1.09

0.06

1.6

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

105

0.86

0.06

2.6

2.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

497

0.97

0.06

1.5

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

119

1.09

0.06

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

151

0.93

0.05

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

495

0.97

0.05

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

108

1097

0.98

0.04

2.4

3.4

u/ml

82.3

780.8

1.96

1002

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

180

1.06

0.04

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

111

1.08

0.04

1.7

1.6

ug/l

4.7

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

369

1.03

0.03

1.1

1.2

—

(4146454)

559

1.02

0.03

2.5

2.7

—

(3017569) Oxygen content in Arterial blood

241

1.04

0.02

3.1

2.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

912

9144

1.00

0.02

3.1

3.0

ug/l

0.8

0.03

626

6028

(3003694) ABO and Rh group [Type] in Blood

1307

13044

1.00

0.02

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

202

1.04

0.02

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

298

0.97

0.02

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

123

1.06

0.01

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

542

1.01

0.01

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

547

0.99

0.01

1.4

1.7

—

(3035880) pH of Pleural fluid

274

1.02

0.00

1.1

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

112

0.98

0.00

1.2

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

112

0.98

0.00

1.1

1.2

—

260.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

252

0.99

0.00

1.4

1.3

mmol/l

5.5

6.0

1.70

238

(3026692) Albumin [Mass/volume] in Peritoneal fluid

135

0.96

0.00

1.3

1.5

g/l

11.5

13.2

—

102

(3013727) Leukocytes other/100 leukocytes in Blood

175

1.03

0.00

3.3

3.7

45.8

54.5

1.36

170

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

1.02

0.00

1.8

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

355

1.01

0.00

1.2

1.4

pmol/l

108.2

147.5

0.17

117

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

154

0.97

0.00

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

113

0.97

0.00

1.5

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

117

1.03

0.00

1.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

246

1.02

0.00

3.6

3.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

483

0.99

0.00

2.6

2.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

359

1.00

0.00

1.4

1.3

mmol/l

12.7

12.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.89

0.00

1.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.96

0.00

1.0

1.3

—

640.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.88

0.00

2.0

2.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.97

0.00

1.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.2

—

(44806071)

1.02

0.00

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.96

0.00

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

110

1.00

0.00

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

150

1.00

0.00

1.9

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.99

0.00

1.3

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

44.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

46.4

—

(3044007) Cell count panel - Peritoneal fluid

150

1.00

0.00

2.5

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

130

1.00

0.00

1.5

1.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

2814.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_MUSCULOSKELEOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_MUSCULOSKELEOTH	1.409 [1.26, 1.58]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.409

During the follow-up period (1.1.1998 — 31.12.2019), 2181 out of 11712 females with M13_MUSCULOSKELEOTH died.

Males

Parameter	HR [95% CI]	p-value
M13_MUSCULOSKELEOTH	1.31 [1.17, 1.47]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1812 out of 10577 males with M13_MUSCULOSKELEOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_MUSCULOSKELEOTH.

N-year risk	Females	Males
1	0.159%	0.27%
5	0.828%	1.402%
10	2.178%	3.571%
15	4.184%	6.955%
20	7.422%	11.411%

Relationships between endpoints

↥

Index endpoint: M13_MUSCULOSKELEOTH – Other disorders of the musculoskeletal system and connective tissue

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of the musculoskeletal system and connective tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints